Clinical Trial Update: A Multicenter, Open-label, Phase 1b Study of Carfilzomib, Cyclophosphamide and Dexamethasone in Newly Diagnosed Multiple Myeloma Subjects [Phase 1]

View source ↗

Summary

A multicenter, open-label Phase 1b trial examines the combination of carfilzomib, cyclophosphamide, and dexamethasone in newly diagnosed multiple myeloma, with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Cytoxan (cyclophosphamide) (cyclophosphamide)
• Decadron (dexamethasone) (dexamethasone)
• Kyprolis (carfilzomib) (carfilzomib)

Snippet

Sponsor: Amgen | Conditions: Multiple Myeloma | Phase 1 | Status: COMPLETED | Results posted: 2016-10-31